MGFZX
Price
$10.77
Change
+$0.02 (+0.19%)
Updated
Sep 26 closing price
Net Assets
151.56M
RPEBX
Price
$70.73
Change
+$0.36 (+0.51%)
Updated
Sep 26 closing price
Net Assets
161.39B
Interact to see
Advertisement

MGFZX vs RPEBX

Header iconMGFZX vs RPEBX Comparison
Open Charts MGFZX vs RPEBXBanner chart's image
MassMutual Global I
Price$10.77
Change+$0.02 (+0.19%)
VolumeN/A
Net Assets151.56M
American Funds New Perspective R2E
Price$70.73
Change+$0.36 (+0.51%)
VolumeN/A
Net Assets161.39B
MGFZX vs RPEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MGFZX vs. RPEBX commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGFZX is a Hold and RPEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RPEBX has more cash in the bank: 161B vs. MGFZX (152M). RPEBX pays higher dividends than MGFZX: RPEBX (0.12) vs MGFZX (0.00). MGFZX was incepted earlier than RPEBX: MGFZX (12 years) vs RPEBX (11 years). RPEBX (1.21) is less costly to investors than MGFZX (0.93). RPEBX is a more actively managed with annual turnover of: 24.00 vs. MGFZX (6.00). MGFZX has a lower initial minimum investment than RPEBX: MGFZX (0) vs RPEBX (250). RPEBX annual gain was more profitable for investors over the last year : 10.20 vs. MGFZX (-6.10). RPEBX return over 5 years is better than : 37.72 vs. MGFZX (-26.98).
MGFZXRPEBXMGFZX / RPEBX
Total Expense Ratio0.931.2177%
Annual Report Gross Expense Ratio0.931.2177%
Fund Existence12 years11 years-
Gain YTD10.12317.16159%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets152M161B0%
Annual Yield % from dividends0.000.12-
Returns for 1 year-6.1010.20-60%
Returns for 3 years-0.2859.79-0%
Returns for 5 years-26.9837.72-72%
Returns for 10 years-17.18103.91-17%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APDN4.141.23
+42.27%
Applied DNA Sciences Inc
EQ1.500.10
+7.14%
Equillium
RTO24.700.59
+2.45%
Rentokil Initial plc
EFSC58.840.22
+0.38%
Enterprise Financial Services Corp
BWMX12.82-0.10
-0.77%
Betterware de Mexico SAPI de CV